Related content

Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer

By Lee K.-W.   Park S.   Oh D.-Y.   Park Y.-I.   Khosravan R.   Lin X.   Lee S.-Y.   Roh E.-J.   Valota O.   Lechuga M.   Bang Y.-J.  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1547-1558

Springer Publishing Company

Access to resources Recommend Favorite

Capecitabine combined with docetaxel versus vinorelbine followed by capecitabine maintenance medication for first-line treatment of patients with advanced breast cancer: Phase 3 randomized trial

By  

Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. : 3412-3421

Blackwell Publishing

Access to resources Recommend Favorite

Capecitabine monotherapy is an effective and well tolerated first-line treatment for patients with advanced or metastatic gastric cancer

By  

Inpharma, Vol. 1, Iss. 1457, 2004-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer

By Boku Narikazu   Muro Kei   Machida Nozomu   Hashigaki Satoshi   Kimura Nobuyuki   Suzuki Mie   Lechuga Mariajose   Miyata Yoshinori  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 261-270

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: Results of a prospective randomized phase II study

By Esteban Emilio   Fra Joaquin   Fernández Yolanda   Corral Norberto   Vieitez José   Palacio Isabel   Sande José   Fernández José   Muñiz Isabel   Villanueva Noemi   Estrada Enrique   Mareque Beatriz   Uña Esther   Buesa José   Lacave Angel  

Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. : 241-248

Springer Publishing Company

Access to resources Recommend Favorite